(PDF) Profile of Changes in Bone Turnover Markers During

Profile of Changes in Bone Turnover Markers During Once-Weekly Teriparatide Administration for 24 Weeks in Postmenopausal Women With Osteoporosis

Osteoporosis International - United Kingdom

doi 10.1007/s00198-013-2516-1

Full Text

Abstract

Available in full text

Categories

Date

October 10, 2013

Authors

Publisher

Springer Science and Business Media LLC

Related search

New Simulation Model for Bone Formation Markers in Osteoporosis Patients Treated With Once-Weekly Teriparatide

English

Treatment Responses With Once-Weekly Teriparatide Therapy for Osteoporosis

Osteoporosis International

English

Endogenous Intact PTH Is Suppressed During Teriparatide (rhPTH 1-34) Administration in Postmenopausal Women With Established Osteoporosis

Endocrine Journal

English

Study of Twice-Weekly Injections of Teriparatide by Comparing Efficacy With Once-Weekly Injections in Osteoporosis Patients: The TWICE Study

Osteoporosis International

English

Effects of Alendronate on the Markers of Bone Metabolic Activity in Postmenopausal Women With Osteoporosis

Medicinski Pregled

English

Vertebral Fracture Risk After Once-Weekly Teriparatide Injections: Follow-Up Study of Teriparatide Once-Weekly Efficacy Research (TOWER) Trial

Current Medical Research and Opinion

English

Changes in Cytokines, Biomarkers of Bone Turnover and Hormones Are Associated With Bone Loss in Postmenopausal Indian Women

International Journal of Endocrinology and Metabolism

English

Oral Weekly Ibandronate Prevents Bone Loss in Postmenopausal Women

Journal of Internal Medicine

Internal Medicine

English

Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture With Once-Weekly Teriparatide

Case Reports in Orthopedics

English